Theo Hoofwijk, MD, Vice President and General Manager, Interventional Studies - Evidera

Theo Hoofwijk

MD, Vice President and General Manager, Interventional Studies, Real-World Evidence

Theo, based in the Netherlands, provides senior level strategy and direction for the practice ensuring scientific and operations excellence are aligned. He brings more than 20 years of experience working within CROs and the pharmaceutical industry, including a wealth of experience in drug safety, clinical drug development, and medical affairs research in both local country operations and corporate pharma environment. During his career, he led strategic drug development activities for pharma customers and managed global programs in the cardiovascular and gastroenterology therapeutic areas. His contributions to the field include developing, leading, and supporting clinical development programs in functional bowel diseases, dyslipidemia, acute coronary syndromes, coronary artery disease, heart failure, hypertension, type 2 diabetes mellitus, and orthotopic liver transplantation.

Prior to joining Evidera, Theo was employed by Quintiles where he held the positions of global medical head cardiovascular/metabolic, therapeutic strategy lead, regional chief medical officer EMEA, and head of strategic drug development APAC. He is a graduate of the University of Amsterdam, from which he received his medical degree.